Researchers analyzed the gut microbiota to study the differences in its composition among patients with Henoch-Schönlein purpura nephritis vs healthy individuals.
Marcus Säemann, MD, talks about the role of SGLT-2 inhibitors and their strong nephroprotective potential that may benefit patients with ANCA-associated vasculitis and lupus nephritis.
The prevalence and risk factors for rheumatoid arthritis-related bronchiectasis are investigated.
At an ACR Convergence 2021 session, John Aucott, MD, and Sheila Arvikar, MD, discussed the various aspects of Lyme arthritis, including incidence, prevalence, symptoms, and treatments, and other tick-borne illnesses, to inform rheumatologists in practice.
Researchers evaluated the link between hydroxychloroquine use and corrected QT length in patients with SLE and RA without cardiovascular disease.
Researchers compared the grade 12 test results of patients with childhood-onset chronic rheumatic diseases and healthy participants, and determined the factors associated with these test scores.
Researchers compared treatment outcomes among patients with psoriatic arthritis who received treatment with TNFi plus csDMARD therapy vs TNFi monotherapy.
This study aimed to identify a CVD risk calculator for clinical use to identify patients with RA who are also at risk of developing CVD.
The role of immunoglobulin A (IgA) anti-citrullinated protein antibodies (ACPA) in patients with rheumatoid arthritis (RA) flares is examined.
The American College of Rheumatology (ACR) developed and validated new Juvenile Arthritis Disease Activity Score 10 (JADAS10) and clinical JADAS10 cutoffs to distinguish between the disease activity states in children with oligoarthritis and polyarthritis.
